Percutaneous mitral valve repair with the mitraclip system according to the predicted risk by the logistic EuroSCORE: Preliminary results from the German Transcatheter Mitral Valve Interventions (TRAMI) registry

Catheterization and Cardiovascular Interventions

Volumn 84, Issue 4, 2014, Pages 591-598

  Wiebe, Jens ^a   Franke, Jennifer ^a   Lubos, Edith ^b   Boekstegers, Peter ^c   Schillinger, Wolfgang ^d   Ouarrak, Taoufik ^e   May, Andreas E ^f   Eggebrecht, Holger ^g   Kuck, Karl Heinz ^h   Baldus, Stephan ⁱ   Senges, Jochen ^e   Sievert, Horst ^a  

^a CARDIOVASCULAR CENTER FRANKFURT   (Germany)

^b UNIVERSITY HEART CENTER HAMBURG   (Germany)

^c Heart Center Siegburg   (Germany)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e Foundation Stiftung Institut für Herzinfarktforschung   (Germany)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^g CARDIOANGIOLOGISCHES CENTRUM BETHANIEN   (Germany)

^h DEPARTMENT OF CARDIOLOGY   (Germany)

ⁱ UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

inoperable; logistic EuroScore; MitraClip; mitral valve regurgitation; percutaneous mitral valve repair

Indexed keywords

AGED; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE REGISTRY; DISEASE SEVERITY; EUROSCORE; FEMALE; HIGH RISK PATIENT; HUMAN; IMPLANTABLE CLIP; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MORTALITY; MULTICENTER STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PREDICTION; PREDICTIVE VALUE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SURGICAL RISK; TREATMENT RESPONSE; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; DEVICES; FEASIBILITY STUDY; GERMANY; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PATHOPHYSIOLOGY; PATIENT SELECTION; PROSTHESIS; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIAC CATHETERIZATION; CHI-SQUARE DISTRIBUTION; FEASIBILITY STUDIES; FEMALE; GERMANY; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PATIENT SELECTION; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84923352182     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25493     Document Type: Article

References (26)

1. Chiam PT, Ruiz CE,. Percutaneous transcatheter mitral valve repair: A classification of the technology. JACC Cardiovasc Interv 2011; 4: 1-13.
2. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS,; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008; 52: e1-142.
3. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M,. Guidelines on the management of valvular heart disease (version 2012): The joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012; 33: 2451-2496.
4. Haan CK, Cabral CI, Conetta DA, Coombs LP, Edwards FH,. Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery. Ann Thorac Surg 2004; 78: 820-825.
5. Mehta RH, Eagle KA, Coombs LP, et al. Influence of age on outcomes in patients undergoing mitral valve replacement. Ann Thorac Surg 2002; 74: 1459-1467.
6. Nowicki ER, Birkmeyer NJ, Weintraub RW, et al. Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in Northern New England. Ann Thorac Surg 2004; 77: 1966-1977.
7. Goodney PP, Lucas FL, Birkmeyer JD,. Should volume standards for cardiovascular surgery focus only on high-risk patients? Circulation 2003; 107: 384-387.
8. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L,; EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011; 364: 1395-1406.
9. Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R, Whitlow PL, Gray W, Low R, Herrmann HC, Lim S, Foster E, Glower D,; EVEREST Investigators. Percutaneous mitral repair with the MitraClip system: Safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 2009; 54: 686-694.
10. Franzen O, Baldus S, Rudolph V, Meyer S, Knap M, Koschyk D, Treede H, Barmeyer A, Schofer J, Costard-Jäckle A, Schlüter M, Reichenspurner H, Meinertz T,. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: Emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 2010; 31: 1373-1381.
11. Tamburino C, Ussia GP, Maisano F, Capodanno D, La Canna G, Scandura S, Colombo A, Giacomini A, Michev I, Mangiafico S, Cammalleri V, Barbanti M, Alfieri O,. Percutaneous mitral valve repair with the MitraClip system: Acute results from a real world setting. Eur Heart J 2010; 31: 1382-1389.
12. Roques F, Michel P, Goldstone AR, Nashef SA,. The logistic EuroSCORE. Eur Heart J 2003; 24: 882-883.
13. Baldus S, Schillinger W, Franzen O, Bekeredjian R, Sievert H, Schofer J, Kuck KH, Konorza T, Möllmann H, Hehrlein C, Ouarrak T, Senges J, Meinertz T,; German Transcatheter Mitral Valve Interventions (TRAMI) investigators. MitraClip therapy in daily clinical practice: Initial results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail 2012; 14: 1050-1055.
14. Brooks R,. EuroQol: The current state of play. Health Policy 1996; 37: 53-72.
15. Paranskaya L, D'Ancona G, Bozdag-Turan I, Akin I, Kische S, Turan GR, Divchev D, Rehders TC, Schneider H, Ortak J, Nienaber CA, Ince H,. Early and mid-term outcomes of percutaneous mitral valve repair with the MitraClip®: Comparative analysis of different EuroSCORE strata. EuroIntervention 2012; 8: 571-578.
16. Maisano F, Franzen O, Baldus S, Hausleiter J, Butter C, Schaefer U, Pedrazzini GB, Schillinger W,. ACCESS EU investigators. MitraClip therapy demonstrates favourable mid-term outcomes in ACCESS-EUROPE heart failure patients with left ventricular ejection fraction 30%: Preliminary report from the 6-month ACCESS-EU analysis cohort. EuroIntervention 2011; 7 (Suppl M).
17. Schillinger W, Athanasiou T, Weicken N, Berg L, Tichelbäcker T, Puls M, Hünlich M, Wachter R, Helms HJ, Seipelt R, Schöndube FA, Hasenfuss G,. Impact of the learning curve on outcomes after percutaneous mitral valve repair with MitraClip and lessons learned after the first 75 consecutive patients. Eur J Heart Fail 2011; 13: 1331-1339.
18. Gurvitch R, Tay EL, Wijesinghe N, Ye J, Nietlispach F, Wood DA, Lichtenstein S, Cheung A, Webb JG,. Transcatheter aortic valve implantation: Lessons from the learning curve of the first 270 high-risk patients. Catheter Cardiovasc Interv 2011; 78: 977-984.
19. Lehmann R, Hemmann K, Weber J, Sirotina M, Sievert H, Wunderlich N, Moritz A, Zeiher AM, Schächinger V, Doss M, Fichtlscherer S,. The STS-Score outperforms the EuroSCORE in predicting outcome following transcatheter aortic valve implantation (TAVI). Transcatheter Cardiovascular Therapeutics (TCT) Meeting, 7-11 Nov 2011; San Francisco, California.
20. Maisano F, Franzen O, Baldus S, Schäfer U, Hausleiter J, Butter C, Ussia GP, Sievert H, Richardt G, Widder JD, Moccetti T, Schillinger W,. Percutaneous mitral valve interventions in the real world: Early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol 2013; 62: 1052-1061.
21. Whitlow PL, Feldman T, Pedersen WR, Lim DS, Kipperman R, Smalling R, Bajwa T, Herrmann HC, Lasala J, Maddux JT, Tuzcu M, Kapadia S, Trento A, Siegel RJ, Foster E, Glower D, Mauri L, Kar S,; EVEREST II Investigators. Acute and 12-month results with catheter-based mitral valve leaflet repair: The EVEREST II (endovascular valve edge-to-edge repair) high risk study. J Am Coll Cardiol 2012; 59: 130-139.
22. Lorusso R, Gelsomino S, Vizzardi E, D'Aloia A, De Cicco G, Lucà F, Parise O, Gensini GF, Stefàno P, Livi U, Vendramin I, Pacini D, Di Bartolomeo R, Miceli A, Varone E, Glauber M, Parolari A, Giuseppe Arlati F, Alamanni F, Serraino F, Renzulli A, Messina A, Troise G, Mariscalco G, Cottini M, Beghi C, Nicolini F, Gherli T, Borghetti V, Pardini A, Caimmi PP, Micalizzi E, Fino C, Ferrazzi P, Di Mauro M, Calafiore AM,; ISTIMIR Investigators. Mitral valve repair or replacement for ischemic mitral regurgitation? The Italian Study on the Treatment of Ischemic Mitral Regurgitation (ISTIMIR). Thorac Cardiovasc Surg 2013; 145: 128-139.
23. Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, Smith PK, Hung JW, Blackstone EH, Puskas JD, Argenziano M, Gammie JS, Mack M, Ascheim DD, Bagiella E, Moquete EG, Ferguson TB, Horvath KA, Geller NL, Miller MA, Woo YJ, D'Alessandro DA, Ailawadi G, Dagenais F, Gardner TJ, O'Gara PT, Michler RE, Kron IL,; the CTSN. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 2014; 370: 23-32.
24. Flameng W, Herijgers P, Bogaerts K,. Recurrence of mitral valve regurgitation after mitral valve repair in degenerative valve disease. Circulation 2003; 107: 1609-1613.
25. Piazza N, Wenaweser P, van Gameren M, Pilgrim T, Tzikas A, Otten A, Nuis R, Onuma Y, Cheng JM, Kappetein AP, Boersma E, Juni P, de Jaegere P, Windecker S, Serruys PW,. Relationship between the logistic EuroSCORE and the society of thoracic surgeons predicted risk of mortality score in patients implanted with the CoreValve ReValving system-A Bern-Rotterdam study. Am Heart J 2010; 159: 323-329.
26. Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U,. EuroSCORE II. Eur J Cardiothorac Surg 2012; 41: 734-745.